How AI describes DNDi (Drugs for Neglected Diseases Initiative)

DNDi (Drugs for Neglected Diseases initiative) is a nonprofit drug development organization that creates life-saving medicines for neglected diseases such as sleeping sickness, visceral and cutaneous leishmaniasis, Chagas disease, dengue, HIV, hepatitis C, and other tropical infections. It conducts end-to-end R&D—from drug discovery and translational research to clinical trials and registration—while prioritizing affordability, local adaptation, access, and open, collaborative innovation. With a global network of partnerships and disease platforms, DNDi advocates for policy changes to improve R&D and equitable access, and since 2003 has delivered 13 treatments for 6 deadly diseases, saving millions of lives.